Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT05464940Not ApplicableNot Yet Recruiting

Impact of Intravenous Caffeine on Atrial Electrical Properties and Potential Arrythmia Induction

Role: collaborator

NCT06672861Not ApplicableNot Yet Recruiting

Development and Validation of the Kansas City Cardiac Dysautonomia Questionnaire (KCDysQ)

Role: collaborator

NCT05464537Not ApplicableTerminated

Efficacy Rate of Unipolar Polarity Switch for Lesion Assessment in Pulmonary Vein Isolation

Role: collaborator

All 3 trials loaded